Cytek Biosciences (CTKB) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 9, 2026.

Voting matters and shareholder proposals

• Election of three Class II director nominees for three-year terms expiring at the 2029 annual meeting.

• Advisory vote to approve executive compensation for the year ended December 31, 2025.

• Ratification of Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026.

• Provision for any other business that may properly come before the meeting.

Board of directors and corporate governance

• Director nominees are Vera Imper, Ph.D., Glenn P. Muir, and Ming Yan, Ph.D.

• Each nominee is proposed for a three-year term, subject to earlier death, resignation, or removal.